News

Newsmogrifydigital2020-11-10T15:51:05+00:00

FEATURED

CONTENT

Mogrify introduces EpiMOGRIFY platform to systematically identify epigenetic switches driving cell identity and cell maintenance

EpiMOGRIFY, published in Cell Systems, is Mogrify®’s second platform that enables the systematic identification of epigenetic switches driving cell identity and cell maintenance.

EpiMOGRIFY enables the identification of the optimal culture conditions required to maintain cells in chemically defined media, enhancing cell conversions to support cGMP cultures and the development of scalable off-the-shelf therapies for diseases with a high unmet clinical need.

Latest

NEWS

Mogrify wins Innovation Award and Dr. Jane Osbourn, OBE receives Lifetime Achievement Award at Scrip Awards 2019

Mark Cavanagh2020-11-23T16:05:44+00:005th December 2019|

Mogrify wins Seed Stage Finance Raise of the Year at 2019 European Lifestars Awards

Mark Cavanagh2020-11-23T16:06:25+00:0020th November 2019|

Mogrify named ‘The One to Watch’ at Cambridge Independent Science and Technology Awards 2019

Mark Cavanagh2020-11-23T16:07:12+00:0031st October 2019|

Mogrify raises additional $16 million to advance its mission to transform the development of life-saving cell therapies

Mark Cavanagh2020-11-23T16:02:12+00:0014th October 2019|

Mogrify appoints Dr. Jane Osbourn, OBE as Chair

mogrifydigital2020-11-23T16:02:50+00:009th September 2019|

Mogrify to host careers open day at Bio-Innovation Centre, Cambridge Science Park

mogrifydigital2020-11-23T16:03:32+00:0016th July 2019|

Load More Posts

Latest

Resources

VIEW ALL RESOURCES

VIEW ALL MEDIA FEATURES

VIEW ALL EVENTS

Follow Us On

Social Media